Neo-adjuvant hormone therapy for non-metastatic prostate cancer: a systematic review and meta-analysis of 5,194 patients

BACKGROUND: Neo-adjuvant hormone therapy (NHT) following radical prostatectomy (RP) or radiotherapy has been utilized in the multimodal approach to patients with intermediate- to high-risk prostate cancer (PCa). Herein, we performed a systematic review and meta-analysis of published randomized trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jimeng, Xu, Hua, Zhu, Wenhui, Wu, Fei, Wang, Jianqing, Ding, Qiang, Jiang, Haowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344800/
https://www.ncbi.nlm.nih.gov/pubmed/25884478
http://dx.doi.org/10.1186/s12957-015-0503-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344800/
https://www.ncbi.nlm.nih.gov/pubmed/25884478
http://dx.doi.org/10.1186/s12957-015-0503-z

Ejemplares similares